Atlas Trials

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280

Clinical trial NCT00681746 · COMPLETED

Trial details

NCT number
NCT00681746
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anxiety
Start date
2008-02-01
Primary completion
2008-09-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.